More than 8 million Americans live with psoriasis every day. Living with the chronic disease can be a long journey for many ...

Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...

Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While ...

Risankizumab was associated with more significant improvements among patients with plaque psoriasis when compared with other biologic therapies.

In the treatment of psoriasis, preliminary evidence supports the hypothesis that IL-23 inhibitors are capable of extended ...

A group of researchers have created four novel laboratory-developed tests that can distinguish between and subclassify atopic dermatitis and psoriasis in a skin biopsy, according to a press release.

Recent study findings highlight the value of integrating behavioral modification and Health Belief Model–based education into ...

The psoriasis market is estimated at $30 Billion by 2030 and has shifted significantly to oral drugsRamat Gan, Israel, March 24, 2025 (GLOBE ...

A recent review highlights how the Mediterranean diet can reduce inflammation and improve outcomes for chronic skin ...

Can-Fite’s CEO expressed confidence in Piclidenoson’s safety and effectiveness for chronic psoriasis treatment. Upon successful outcomes, the company plans to seek regulatory approval for the ...

Turkey: A decade-long study from a tertiary care hospital highlights the effectiveness and safety of narrow-band ultraviolet ...